At the end of the session, you will be able to:
In this podcast, two data specialists discuss the ways in which Medical Affairs professionals can use this data to discover your next generation of researchers, those influencers whose voices are heard on Twitter, and how your KOLs are interacting with others online.
Customer engagements for Medical Affairs has evolved rapidly post COVID-19. Hybrid is the future and that brings with it new challenges, most notably in sustaining engagements with the KOLs to become unbiased scientific partners of choice. As a result, there have been shifts in strategies: newer roles, newer stakeholders to be engaged, and more data and information collected.
There is no one-size-fits-all approach. The intent of this webinar will be to have a discussion on which strategies are working, and how leading companies are defining success for field medical teams in hybrid engagements.
In today’s rapidly evolving pharmaceutical environment, Medical Affairs teams are under increasing pressure to understand how to go beyond “activity engagement” metrics and identify areas of opportunity to advance evidenced-based medicine and treatment with current available data.
This webinar will provide a historical perspective on value, as well as insights to help Medical Affairs professionals measure and demonstrate the impact of their activities in a complex environment.
As Medical Affairs teams strive to identify areas of opportunity and demonstrate their value, understanding the importance of data-driven strategies is essential. In this webinar, we will discuss the historical perspective on value in Medical Affairs, as well as strategies to measure and demonstrate impact in an evolving pharmaceutical environment. Join us to learn more about how data-driven strategies can help you gain a better understanding of your Medical Affairs activities and provide insights into areas of opportunity.
In this episode, listeners will better understand what innovative content is in the context of Medical Information while setting expectations of HCPs in accessing innovative content.
Medical Affairs plays a critical strategic role in product launches, through scientific knowledge, clinical expertise and cross-functional collaboration. Comprehensive research of international product launches, with an objective set of criteria, has shown that less than 10% of recent launches were excellent. This research has also revealed that two key dimensions, unmet need and product differentiation, have the highest influence on launch success, and enabled the definition of four clear launch archetypes. The launch archetypes help to identify critical success factors (CSFs) to develop the most effective launch strategy, and facilitate launch planning. The CSFs also highlight the key areas where Medical Affairs can make the highest strategic impact to support product success and improve patient outcomes.
Through review of launch archetypes, product launch case studies and MAPS launch excellence guidelines, this webinar will examine, based on the prevailing pre-launch situation, the strategic focus areas for Medical Affairs teams to consider during launch preparation and discuss approaches to achieve excellence across key activities.
In this episode, our expert speakers explain how to create eLearning resources that are relevant, credible and evidence-based.
The session will focus on results from first hand experiences in Chat GPT and other Large Language Models (LLMs), themes will include:
All industries are rushing to harness rich data in order to drive progress, but how can the many data sources help Medical Affairs to show impact and drive improved patient outcomes?
In part three of this four-part series, we will discuss:
This Webinar series explores the fundamental concept of big data in Medical Affairs, from which sources can we retrieve this, what are the broader considerations when utilizing data in health and what impact this can have on our organizations, physicians, and patients, now and in the future. These presentations will feature real-world cases that are relevant to regional and country Medical Affairs leaders, in order to highlight long-term aspirational and short-term tangible projects.
While the value of patient engagement is increasingly recognised in the clinical and launch phases of drug development, it is still a relatively new concept to involve patients in the early discovery phase. By understanding the burden of disease and patient’s aspirations for new treatments from the outset, pharma companies can ensure they are developing medicines that matter to patients. As experts in the disease area and therapeutic landscape, Medical Affairs are well placed to initiate and develop effective patient partnerships to ensure that the patient voice is incorporated during early discovery and beyond.
In this webinar we will explore practical approaches to engaging patients in early development, introducing key resources and discussing best practices. These discussions will be tailored to meet the needs of all Medical Affairs colleagues, regardless of experience.